Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership66,992 shares
Latest Disclosed Value $ 330,940
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 11.26% increase in ownership of VIR / Vir Biotechnology, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 66,992 shares of Vir Biotechnology, Inc. (US:VIR) valued at $330,940 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 60,212 shares of Vir Biotechnology, Inc.. This represents a change in shares of 11.26% during the quarter. The current value of the position is $579,481 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 66,992 6,780 11.26 331 -34.65 0.0044
2025-04-25 2025-02-28 NP VIR BIOTECHNOLOGY EC US92764N1028 60,212 1,620 2.76 505 8.37 0.0068
2025-01-27 2024-11-30 NP VIR BIOTECHNOLOGY EC US92764N1028 58,592 420 0.72 466 -2.92 0.0063
2024-10-29 2024-08-31 NP VIR BIOTECHNOLOGY EC US92764N1028 58,172 -8,928 -13.31 480 -30.33 0.0071
2024-07-26 2024-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 67,100 32,237 92.47 689 -25.83 0.0109
2023-07-26 2023-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 34,863 114 0.33 930 17.30 0.0201
2023-04-27 2023-02-28 NP VIR BIOTECHNOLOGY EC US92764N1028 34,749 855 2.52 792 -17.15 0.0194
2023-01-26 2022-11-30 NP VIR BIOTECHNOLOGY EC US92764N1028 33,894 893 2.71 956 22.09 0.0239
2022-10-26 2022-08-31 NP VIR BIOTECHNOLOGY EC US92764N1028 33,001 9,160 38.42 784 27.32 0.0196
2022-07-29 2022-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 23,841 728 3.15 615 5.67 0.0157
2022-04-28 2022-02-28 NP VIR BIOTECHNOLOGY EC US92764N1028 23,113 364 1.60 582 -46.01 0.0135
2022-01-25 2021-11-30 NP VIR BIOTECHNOLOGY EC US92764N1028 22,749 2,582 12.80 1,079 3.75 0.0225
2021-10-26 2021-08-31 NP VIR BIOTECHNOLOGY EC US92764N1028 20,167 -6,085 -23.18 1,039 -5.55 0.0228
2021-07-22 2021-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 26,252 523 2.03 1,100 -31.72 0.0273
2021-04-23 2021-02-28 NP VIR BIOTECHNOLOGY EC US92764N1028 25,729 5,053 24.44 1,611 144.46 0.0420
2021-01-20 2020-11-30 NP VIR BIOTECHNOLOGY EC US92764N1028 20,676 -3,336 -13.89 659 -32.20 0.0197
2020-10-16 2020-08-31 NP VIR BIOTECHNOLOGY EC US92764N1028 24,012 2,229 10.23 972 30.65 0.0300
2020-07-20 2020-05-31 NP VIR BIOTECHNOLOGY EC US92764N1028 21,783 7,131 48.67 745 9.25 0.0291
2020-04-24 2020-02-29 NP VIR BIOTECHNOLOGY EC US92764N1028 14,652 14,652 681 0.0304
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.